Literature DB >> 30082473

Family History of Breast or Prostate Cancer and Prostate Cancer Risk.

Lauren Barber1,2, Travis Gerke1,3, Sarah C Markt1, Samuel F Peisch4, Kathryn M Wilson1,5, Thomas Ahearn1,6, Edward Giovannucci1,5,7, Giovanni Parmigiani1,8,9, Lorelei A Mucci4,5.   

Abstract

PURPOSE: Breast and prostate cancer co-occur in families, and women with a family history of prostate cancer are at increased breast cancer risk. Prostate cancer is among the most heritable cancers, but few studies have investigated its association with familial breast cancer. The objective of this study is to investigate the extent to which familial breast or prostate cancer in first-degree relatives increases prostate cancer risk. EXPERIMENTAL
DESIGN: A prospective study of 37,002 U.S. men in the Health Professionals Follow-up Study. During the 16-year follow-up to 2012, 4,208 total and 344 lethal cases were diagnosed. Using cause-specific hazards regression, we estimated the multivariable HRs and 95% confidence intervals (CI) for associations between familial breast or prostate cancer and total and lethal prostate cancer.
RESULTS: Those with familial breast cancer had a 21% greater risk of prostate cancer overall (95% CI, 1.10-1.34), and a 34% greater risk of lethal disease (HR 1.34; 95% CI, 0.96-1.89). Family history of prostate cancer alone was associated with a 68% increased risk of total disease (95% CI, 1.53-1.83) and a 72% increased risk of lethal disease (95% CI, 1.25-2.38). Men with a family history of both cancers were also at elevated risk.
CONCLUSIONS: Our study found that men with a family history of breast or prostate cancer had elevated prostate cancer risks, including risk of lethal disease. These findings have translational relevance for cancer risk prediction in men. ©2018 American Association for Cancer Research.

Entities:  

Mesh:

Year:  2018        PMID: 30082473      PMCID: PMC6279573          DOI: 10.1158/1078-0432.CCR-18-0370

Source DB:  PubMed          Journal:  Clin Cancer Res        ISSN: 1078-0432            Impact factor:   12.531


  28 in total

1.  Familial aggregation of prostate cancer in African-Americans and white Americans.

Authors:  Glenn R Cunningham; Carol M Ashton; John F Annegers; Julianne Souchek; Marcella Klima; Brian Miles
Journal:  Prostate       Date:  2003-09-01       Impact factor: 4.104

2.  Risk factors for prostate cancer incidence and progression in the health professionals follow-up study.

Authors:  Edward Giovannucci; Yan Liu; Elizabeth A Platz; Meir J Stampfer; Walter C Willett
Journal:  Int J Cancer       Date:  2007-10-01       Impact factor: 7.396

3.  When do we need competing risks methods for survival analysis in nephrology?

Authors:  Marlies Noordzij; Karen Leffondré; Karlijn J van Stralen; Carmine Zoccali; Friedo W Dekker; Kitty J Jager
Journal:  Nephrol Dial Transplant       Date:  2013-08-24       Impact factor: 5.992

4.  Family history of breast cancer as a predictor for fatal prostate cancer.

Authors:  C Rodríguez; E E Calle; L M Tatham; P A Wingo; H L Miracle-McMahill; M J Thun; C W Heath
Journal:  Epidemiology       Date:  1998-09       Impact factor: 4.822

Review 5.  Biases in Recommendations for and Acceptance of Prostate Biopsy Significantly Affect Assessment of Prostate Cancer Risk Factors: Results From Two Large Randomized Clinical Trials.

Authors:  Catherine M Tangen; Phyllis J Goodman; Cathee Till; Jeannette M Schenk; M Scott Lucia; Ian M Thompson
Journal:  J Clin Oncol       Date:  2016-10-28       Impact factor: 44.544

6.  Replication of prostate cancer risk loci on 8q24, 11q13, 17q12, 19q33, and Xp11 in African Americans.

Authors:  Stanley Hooker; Wenndy Hernandez; Hankui Chen; Christiane Robbins; Jada Benn Torres; Chiledum Ahaghotu; John Carpten; Rick A Kittles
Journal:  Prostate       Date:  2010-02-15       Impact factor: 4.104

7.  Familial clustering of breast and prostate cancers and risk of postmenopausal breast cancer.

Authors:  T A Sellers; J D Potter; S S Rich; C R Drinkard; R M Bostick; L H Kushi; W Zheng; A R Folsom
Journal:  J Natl Cancer Inst       Date:  1994-12-21       Impact factor: 13.506

8.  Family history and prostate cancer risk in a population-based cohort of Iowa men.

Authors:  J R Cerhan; A S Parker; S D Putnam; B C Chiu; C F Lynch; M B Cohen; J C Torner; K P Cantor
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  1999-01       Impact factor: 4.254

9.  Multiple novel prostate cancer susceptibility signals identified by fine-mapping of known risk loci among Europeans.

Authors:  Ali Amin Al Olama; Tokhir Dadaev; Dennis J Hazelett; Qiuyan Li; Daniel Leongamornlert; Edward J Saunders; Sarah Stephens; Clara Cieza-Borrella; Ian Whitmore; Sara Benlloch Garcia; Graham G Giles; Melissa C Southey; Liesel Fitzgerald; Henrik Gronberg; Fredrik Wiklund; Markus Aly; Brian E Henderson; Fredrick Schumacher; Christopher A Haiman; Johanna Schleutker; Tiina Wahlfors; Teuvo L Tammela; Børge G Nordestgaard; Tim J Key; Ruth C Travis; David E Neal; Jenny L Donovan; Freddie C Hamdy; Paul Pharoah; Nora Pashayan; Kay-Tee Khaw; Janet L Stanford; Stephen N Thibodeau; Shannon K Mcdonnell; Daniel J Schaid; Christiane Maier; Walther Vogel; Manuel Luedeke; Kathleen Herkommer; Adam S Kibel; Cezary Cybulski; Dominika Wokołorczyk; Wojciech Kluzniak; Lisa Cannon-Albright; Hermann Brenner; Katja Butterbach; Volker Arndt; Jong Y Park; Thomas Sellers; Hui-Yi Lin; Chavdar Slavov; Radka Kaneva; Vanio Mitev; Jyotsna Batra; Judith A Clements; Amanda Spurdle; Manuel R Teixeira; Paula Paulo; Sofia Maia; Hardev Pandha; Agnieszka Michael; Andrzej Kierzek; Koveela Govindasami; Michelle Guy; Artitaya Lophatonanon; Kenneth Muir; Ana Viñuela; Andrew A Brown; Mathew Freedman; David V Conti; Douglas Easton; Gerhard A Coetzee; Rosalind A Eeles; Zsofia Kote-Jarai
Journal:  Hum Mol Genet       Date:  2015-05-29       Impact factor: 6.150

10.  Inherited DNA-Repair Gene Mutations in Men with Metastatic Prostate Cancer.

Authors:  Colin C Pritchard; Joaquin Mateo; Michael F Walsh; Navonil De Sarkar; Wassim Abida; Himisha Beltran; Andrea Garofalo; Roman Gulati; Suzanne Carreira; Rosalind Eeles; Olivier Elemento; Mark A Rubin; Dan Robinson; Robert Lonigro; Maha Hussain; Arul Chinnaiyan; Jake Vinson; Julie Filipenko; Levi Garraway; Mary-Ellen Taplin; Saud AlDubayan; G Celine Han; Mallory Beightol; Colm Morrissey; Belinda Nghiem; Heather H Cheng; Bruce Montgomery; Tom Walsh; Silvia Casadei; Michael Berger; Liying Zhang; Ahmet Zehir; Joseph Vijai; Howard I Scher; Charles Sawyers; Nikolaus Schultz; Philip W Kantoff; David Solit; Mark Robson; Eliezer M Van Allen; Kenneth Offit; Johann de Bono; Peter S Nelson
Journal:  N Engl J Med       Date:  2016-07-06       Impact factor: 91.245

View more
  15 in total

1.  Prostate cancer metastasis mimicking a primary urothelial carcinoma of the bladder.

Authors:  Martina Spazzapan; Momen Sid Ahmed; Ali Tasleem; Nkwam Nkwam
Journal:  J Surg Case Rep       Date:  2022-06-14

2.  Defining the Impact of Family History on Detection of High-grade Prostate Cancer in a Large Multi-institutional Cohort.

Authors:  Matthew B Clements; Emily A Vertosick; Lourdes Guerrios-Rivera; Amanda M De Hoedt; Javier Hernandez; Michael A Liss; Robin J Leach; Stephen J Freedland; Alexander Haese; Francesco Montorsi; Stephen A Boorjian; Cedric Poyet; Donna P Ankerst; Andrew J Vickers
Journal:  Eur Urol       Date:  2021-12-31       Impact factor: 24.267

3.  Family history of prostate cancer and the incidence of ERG- and phosphatase and tensin homolog-defined prostate cancer.

Authors:  Dana Hashim; Amparo G Gonzalez-Feliciano; Thomas U Ahearn; Andreas Pettersson; Lauren Barber; Claire H Pernar; Ericka M Ebot; Masis Isikbay; Stephen P Finn; Edward L Giovannucci; Rosina T Lis; Massimo Loda; Giovanni Parmigiani; Tamara Lotan; Philip W Kantoff; Lorelei A Mucci; Rebecca E Graff
Journal:  Int J Cancer       Date:  2019-07-27       Impact factor: 7.396

Review 4.  Application Areas of Traditional Molecular Genetic Methods and NGS in relation to Hereditary Urological Cancer Diagnosis.

Authors:  Dmitry S Mikhaylenko; Alexander S Tanas; Dmitry V Zaletaev; Marina V Nemtsova
Journal:  J Oncol       Date:  2020-06-17       Impact factor: 4.375

5.  Metachronous or synchronous male breast and prostate cancers a duality to lookout for.

Authors:  Alain Mwamba Mukendi; Eunice Van Den Berg; Sugeshnee Pather; Rushen Siva Padayachee
Journal:  F1000Res       Date:  2018-11-20

6.  Assessing the clinical utility of genetic risk scores for targeted cancer screening.

Authors:  Carly A Conran; Zhuqing Shi; William Kyle Resurreccion; Rong Na; Brian T Helfand; Elena Genova; Siqun Lilly Zheng; Charles B Brendler; Jianfeng Xu
Journal:  J Transl Med       Date:  2021-01-22       Impact factor: 5.531

7.  Family history of prostate cancer and prostate tumor aggressiveness in black and non-black men;results from an equal access biopsy study.

Authors:  Kimberly R Jenkins; Taofik Oyekunle; Lauren E Howard; Emily K Wiggins; Stephen J Freedland; Emma H Allott
Journal:  Cancer Causes Control       Date:  2021-02-02       Impact factor: 2.506

Review 8.  Updates in Prostate Cancer Research and Screening in Men at Genetically Higher Risk.

Authors:  Elizabeth K Bancroft; Holly Ni Raghallaigh; Elizabeth C Page; Rosalind A Eeles
Journal:  Curr Genet Med Rep       Date:  2021-10-08

9.  Molecular Expression of Some Oncogenes and Predisposing Behaviors Contributing to the Aggressiveness of Prostate Cancer.

Authors:  Mohammad Ghasem Kashanizadeh; Fariba Rezaei Fakhrnezhad; Saeede Yavari; Homa Alizadeh; Payam Hashemim; Amir Monfaredan
Journal:  Rep Biochem Mol Biol       Date:  2021-04

10.  Data Mining in Healthcare: Applying Strategic Intelligence Techniques to Depict 25 Years of Research Development.

Authors:  Maikel Luis Kolling; Leonardo B Furstenau; Michele Kremer Sott; Bruna Rabaioli; Pedro Henrique Ulmi; Nicola Luigi Bragazzi; Leonel Pablo Carvalho Tedesco
Journal:  Int J Environ Res Public Health       Date:  2021-03-17       Impact factor: 3.390

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.